Paper41553019
Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus.
Vissapragada R and 6 others. J Gastroenterol Hepatol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus. Papers, record 41553019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41553019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Barrett Esophagus | Major topic |
| Cost-Benefit Analysis | Major topic |
| Cost-Effectiveness Analysis | Major topic |
| Esophageal Neoplasms | Major topic |
| Esophagoscopy | Major topic |
| Population Surveillance | Major topic |
| Humans | |
| Markov Chains | |
| Adenocarcinoma | |
| Male | |
| Female | |
| Disease Progression | |
| Time Factors |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Hospital Research Foundation | PubMed | |||
| APAGE/JGH Foundation Clinician-Scientist Training Fellowship | PubMed | |||
| Cancer Council South Australia Beat Cancer Early Career Research Fellowship | PubMed |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21997553 | The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. | Gut | 2012 | https://conductscience.org/library/papers/21997553 | PubMed |
| 2 | 31439127 | ASGE guideline on screening and surveillance of Barrett's esophagus. | Gastrointest Endosc | 2019 | https://conductscience.org/library/papers/31439127 | PubMed |
| 3 | 28389530 | Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia. | Gut | 2018 | https://conductscience.org/library/papers/28389530 | PubMed |
| 4 | 25612140 | Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. | J Gastroenterol Hepatol | 2015 | https://conductscience.org/library/papers/25612140 | PubMed |
| 5 | 26113177 | Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. | Gut | 2016 | https://conductscience.org/library/papers/26113177 | PubMed |
| 6 | 31749626 | A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett's Esophagus. | Clinicoecon Outcomes Res | 2019 | https://conductscience.org/library/papers/31749626 | PubMed |
| 7 | 33480173 | Cost-effectiveness in surgery: concepts of cost-utility analysis explained. | ANZ J Surg | 2021 | https://conductscience.org/library/papers/33480173 | PubMed |
| 8 | 26772891 | Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort. | Gastrointest Endosc | 2016 | https://conductscience.org/library/papers/26772891 | PubMed |
| 9 | 29689573 | Systematic review and meta-analysis of the effectiveness of radiofrequency ablation in low grade dysplastic Barrett's esophagus. | Endoscopy | 2018 | https://conductscience.org/library/papers/29689573 | PubMed |
| 10 | 41553019 | Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus. | J Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41553019 | PubMed |
| 11 | 25935635 | An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling. | Gastroenterology | 2015 | https://conductscience.org/library/papers/25935635 | PubMed |
| 12 | 22644445 | Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia. | J Gastrointest Surg | 2012 | https://conductscience.org/library/papers/22644445 | PubMed |
| 13 | 28374819 | Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis. | Am J Gastroenterol | 2017 | https://conductscience.org/library/papers/28374819 | PubMed |
| 14 | 27882416 | Toward More Efficient Surveillance of Barrett's Esophagus: Identification and Exclusion of Patients at Low Risk of Cancer. | World J Surg | 2017 | https://conductscience.org/library/papers/27882416 | PubMed |
| 15 | 37081811 | Guidance on the use of complex systems models for economic evaluations of public health interventions. | Health Econ | 2023 | https://conductscience.org/library/papers/37081811 | PubMed |
| 16 | 30213587 | Incidence of Progression of Persistent Nondysplastic Barrett's Esophagus to Malignancy. | Clin Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/30213587 | PubMed |
| 17 | 27227114 | Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability. | Endosc Int Open | 2016 | https://conductscience.org/library/papers/27227114 | PubMed |
| 18 | 23542068 | Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. | Gastroenterology | 2013 | https://conductscience.org/library/papers/23542068 | PubMed |
| 19 | 24589668 | Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk. | Am J Gastroenterol | 2014 | https://conductscience.org/library/papers/24589668 | PubMed |
| 20 | 15180723 | Assessment of health state utilities and quality of life in patients with malignant esophageal Dysphagia. | Am J Gastroenterol | 2004 | https://conductscience.org/library/papers/15180723 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41553019 | Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus. | J Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41553019 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41553019
GET https://conductscience.org/api/papers/v1/41553019/references?page=2